These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias. Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers FC, Kremer B, Speel EJ, Klussmann JP. Int J Cancer; 2014 May 01; 134(9):2108-17. PubMed ID: 24127203 [Abstract] [Full Text] [Related]
9. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. Lancet Oncol; 2014 Nov 01; 15(12):1319-31. PubMed ID: 25439690 [Abstract] [Full Text] [Related]
10. p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Pai RK, Erickson J, Pourmand N, Kong CS. Cancer; 2009 Apr 25; 117(2):108-19. PubMed ID: 19365840 [Abstract] [Full Text] [Related]
11. Association study of cell cycle proteins and human papillomavirus in laryngeal cancer in Chinese population. Cui L, Qu C, Liu H. Clin Otolaryngol; 2019 May 25; 44(3):323-329. PubMed ID: 30681775 [Abstract] [Full Text] [Related]
15. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Linxweiler M, Bochen F, Wemmert S, Lerner C, Hasenfus A, Bohle RM, Al-Kadah B, Takacs ZF, Smola S, Schick B. Cancer Cytopathol; 2015 Apr 25; 123(4):219-29. PubMed ID: 25557267 [Abstract] [Full Text] [Related]
19. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T, Alejo M, Holzinger D, Cadena E, Claros E, Hall G, Laco J, Poljak M, Benevolo M, Kasamatsu E, Mehanna H, Ndiaye C, Guimerà N, Lloveras B, León X, Ruiz-Cabezas JC, Alvarado-Cabrero I, Kang CS, Oh JK, Garcia-Rojo M, Iljazovic E, Ajayi OF, Duarte F, Nessa A, Tinoco L, Duran-Padilla MA, Pirog EC, Viarheichyk H, Morales H, Costes V, Félix A, Germar MJ, Mena M, Ruacan A, Jain A, Mehrotra R, Goodman MT, Lombardi LE, Ferrera A, Malami S, Albanesi EI, Dabed P, Molina C, López-Revilla R, Mandys V, González ME, Velasco J, Bravo IG, Quint W, Pawlita M, Muñoz N, de Sanjosé S, Xavier Bosch F, ICO International HPV in Head and Neck Cancer Study Group. J Natl Cancer Inst; 2016 Jun 25; 108(6):djv403. PubMed ID: 26823521 [Abstract] [Full Text] [Related]